COMMUNIQUÉS West-GlobeNewswire

Capricor Therapeutics Announces Closing of Underwritten Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

18/10/2024 - 22:01

SAN DIEGO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, announced [...]

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

18/10/2024 - 22:30

NOVATO, Calif., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultrarare [...]

Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting

18/10/2024 - 22:30

AUDUBON, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, is participating in the 40 th Annual Meeting of the Orthopedic Trauma Association (OTA) in [...]

DBV Technologies participera au prochain congrès de l'ACAAI 2024

18/10/2024 - 22:30

Châtillon, France, le 18 octobre (22 :30 CEST) 2024 DBV Technologies participera au prochain congrès de l'ACAAI 2024 DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock Market : DBVT), société [...]

DBV Technologies to Participate in Upcoming ACAAI 2024 Congress

18/10/2024 - 22:30

Châtillon, France, October 18, 2024 DBV Technologies to Participate in Upcoming ACAAI 2024 Congress DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical [...]

Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

18/10/2024 - 22:31

DURHAM, N.C., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on October 16, 2024, the Compensation Committee of Chimerix’s Board of Directors granted an inducement award to a new employee [...]

Solera Health Study Suggests Virtual Healthcare Networks Can Reduce the Cost of Care by up to 3.1%

17/10/2024 - 15:00

Potential Savings Equate to Over $50 Billion in U.S. Annual Private Insurer Expenditures PHOENIX, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Solera Health , a unique technology platform for connecting people seamlessly and [...]

Outlook Therapeutics® Participates in a Virtual Investor CEO Connect Segment

17/10/2024 - 15:00

Access the CEO Connect segment here ISELIN, N.J., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union and the [...]

Nephros Delivers Critical Disaster Response to Support Hospitals and Care Facilities Impacted by Hurricanes Helene and Milton

17/10/2024 - 15:00

SOUTH ORANGE, N.J., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH) Nephros, Inc., a leader in advanced filtration technology, is proud to announce its rapid response to the recent hurricanes which [...]

Nordic Naturals Completes 40th Annual California Coastal Cleanup with National Retail Support

17/10/2024 - 15:00

WATSONVILLE, Calif., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Nordic Naturals , a worldwide leader in providing premium omega-3 fish oils and other essential nutrient supplements, successfully wrapped up its participation in [...]

RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing

17/10/2024 - 15:15

AMSTERDAM, Oct. 17, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RENB) – RenovaroCube, a leader in AI-driven cancer diagnostics by integrating multi-omics with liquid biopsies, is excited to announce the presentation of its latest [...]

TOMI Environmental Solutions, Inc. Announces Record Q3 2024 iHP Corporate Service Revenue

17/10/2024 - 15:25

FREDERICK, Md., Oct. 17, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination technologies, today announced that its iHP Corporate [...]

Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow

17/10/2024 - 15:32

Total eligible patients in the US exceed 2 million. Treatment of SARS-CoV-2 infection in solid and hematologic cancer patients under active treatment. Reflects business philosophy of commercial success through patient [...]

Avadel Pharmaceuticals Announces FDA Approval of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with Narcolepsy

17/10/2024 - 15:41

-- LUMRYZ is the only FDA-approved once-at-bedtime oxybate treatment for cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy— -- Granted Orphan Drug Exclusivity in [...]

WellRithms Selected for BenefitsPRO’s 2024 Luminaries Awards

17/10/2024 - 16:00

PORTLAND, Ore., Oct. 17, 2024 (GLOBE NEWSWIRE) -- WellRithms , the industry leading payment integrity firm, has been named to BenefitsPRO Luminaries Class of 2024 in the Rising Star category, one of only two recipients [...]

New Study Reveals Promising Outcomes for Minimally Invasive Sacrospinous Ligament Fixation Using EnPlace® for Treating Pelvic Organ Prolapse in Older Women

17/10/2024 - 16:00

NEWARK, Del., Oct. 17, 2024 (GLOBE NEWSWIRE) -- A new study published last week in the “Journal of Clinical Medicine” has revealed promising results for sacrospinous ligament (SSL) fixation using the EnPlace ® device, a [...]

Rapafusyn Pharmaceuticals to Present In Vivo Data on ENT1 Inhibitor for Acute Kidney Injury at the American Society for Nephrology (ASN Kidney Week 2024)

17/10/2024 - 16:24

BALTIMORE, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Rapafusyn Pharmaceuticals, a leader in the field of non-degrading molecular glues, is pleased to announce the upcoming presentation of preclinical in vivo data from its [...]

Dr. Wenming Chen to Receive Asian Myeloma Network Distinguished Service Award at the 8th AMN Summit in Seoul

17/10/2024 - 16:41

International Myeloma Foundation (IMF) to hold AMN Awards Ceremony at the 8th AMN Summit in Seoul, South Korea on Saturday, October 19 SEOUL, South Korea, Oct. 17, 2024 (GLOBE NEWSWIRE) -- The International Myeloma [...]

Emergex Announces Company Name Change to “Gylden Pharma Limited” Reflecting Company’s Commitment to Advanced Core Technologies and Expanded Product Pipeline

17/10/2024 - 17:00

ABINGDON, United Kingdom, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Emergex Vaccines Holding Limited, a clinical-stage biotechnology company that is addressing major global infectious diseases through the development of [...]